FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Actavis Elizabeth Dextroamphetamine Sulfate Extended-Release Recall

Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg, 90-count bottles, Rx Only,…

Actavis Elizabeth LLC · Elizabeth, NJ

Risk level
Class II
Reported by FDA
Mar 11, 2015
Recall ID
D-0395-2015
Check your lot numberHow we source this data

Summary

Actavis Elizabeth recalled Dextroamphetamine Sulfate Extended-Release starting Feb 10, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0395-2015 on Mar 11, 2015. Reason: Failed Dissolution Specifications. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications

Product description

Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg, 90-count bottles, Rx Only, Manufactured by: Actavis Elizabeth LLC, Elizabeth, NJ 07201 USA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA; NDC 45963-305-09, UPC 3 45963-305-09 1.

Lot numbers, UPCs & expiration codes

Lot #: 2020E141, Exp 07/15

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0395-2015
Classification
Class II
Status
Terminated
Recall initiated
Feb 10, 2015
FDA report date
Mar 11, 2015
Quantity
42 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Actavis Elizabeth LLC

Original FDA data

Every field from FDA enforcement report D-0395-2015, exactly as published.

Show all FDA fields
City
Elizabeth
State
NJ
Status
Terminated
Country
United States
Event ID
70522
Address
200 Elmora Ave
Code information
Lot #: 2020E141, Exp 07/15
Postal code
07202-1106
Report date
Mar 11, 2015
Product type
Drugs
Recall number
D-0395-2015
Classification
Class II
Recalling firm
Actavis Elizabeth LLC
Product quantity
42 bottles
Termination date
Aug 14, 2015
Reason for recall
Failed Dissolution Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg, 90-count bottles, Rx Only, Manufactured by: Actavis Elizabeth LLC, Elizabeth, NJ 07201 USA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA; NDC 45963-305-09, UPC 3 45963-305-09 1.
Distribution pattern
Nationwide
Recall initiation date
Feb 10, 2015
Initial firm notification
Letter
Center classification date
Feb 27, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0395-2015, published Mar 11, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls